Trikat MR Angina (35mg) 20 Tablets

Trikat MR is an anti-ischemic metabolic agent containing Trimetazidine Dihydrochloride. It is specifically formulated as a modified-release (MR) tablet to provide a steady therapeutic effect over an extended period. This medication is primarily used by adults for the prophylactic treatment of episodes of stable angina pectoris.

How Trikat MR Works:
Unlike traditional vasodilators, Trimetazidine works by protecting the heart’s metabolism during periods of low oxygen (ischemia). It helps the heart use energy more efficiently, reducing the frequency and severity of chest pain attacks.

Key Benefits:

• Angina Prophylaxis: Effective in reducing the number of angina attacks and the need for short-acting nitrates.

• Modified Release Technology: Designed for a 12-hour release cycle, ensuring consistent levels of the medicine in your system.

• Heart Protection: Helps maintain cellular energy during physical exertion or stress.

Product Specifications:

• Active Ingredient: Trimetazidine Dihydrochloride 35mg

• Formulation: Modified Release Tablets

• Pack Size: 20 Tablets per pack

• Manufacturer: Next Pharmaceutical

Dosage & Administration:
The typical dosage is one tablet (35mg) taken twice daily—once in the morning and once in the evening—during meals. Always follow the specific dosage prescribed by your cardiologist.

Storage:
Keep in a dry place at room temperature (below 30°C). Protect from direct sunlight and keep away from children.

⚠️ Important Medical Warning:
Trikat MR is a prescription-only medicine. It is not intended for the treatment of acute angina attacks; it is a long-term preventative treatment. Consult your doctor or pharmacist if you have Parkinson’s disease, tremors, or severe kidney problems before using this medication. In case of side effects such as dizziness or movement disorders, contact your healthcare provider immediately.